Want to join the conversation?
Healthcare services provider $CAH acquired $JNJ's Cordis business interests for $1.944Bil. $CAH expects FY17 accretion in non-GAAP diluted EPS of $0.20 per share and also expects synergies will exceed $100MM annually by FY18. "I'm extremely pleased to welcome our new Cordis colleagues to $CAH," said George Barrett, Chairman and CEO of $CAH.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.